Utilization of a derivatization method with multidimensional liquid chromatography-mass spectrometry for the detection of neurotransmitters by George, Olivia Kaye
Boston University
OpenBU http://open.bu.edu
Theses & Dissertations Boston University Theses & Dissertations
2020
Utilization of a derivatization
method with multidimensional
liquid chromatography-mass










UTILIZATION OF A DERIVATIZATION METHOD WITH 
MULTIDIMENSIONAL LIQUID CHROMATOGRAPHY-MASS 




OLIVIA KAYE GEORGE 




Submitted in partial fulfillment of the 
requirements for the degree of 






















© 2020 by 
OLIVIA KAYE GEORGE 







First Reader  
 Sabra Botch-Jones, M.S., M.A., D-ABFT-FT 
Assistant Professor, Program in Biomedical Forensic Sciences  
 Department of Anatomy & Neurobiology 
  
  
Second Reader  
 Claude Mallet, Ph.D. 





Third Reader  
 Joshua Wilhide, M.S. 
MCAC Manager 










I would like to express my gratitude to the faculty and staff at Boston University 
especially in the Biomedical Forensic Sciences Program for the opportunity to expand my 
knowledge and gain valuable skills to use in the future. To Sabra Botch-Jones and the rest 
of my research group, I want to thank you for your advice and support during this project. 
To my academic advisor Amy Brodeur and the other professors in the Biomedical 
Forensics program, thank you for teaching me and guiding me throughout my time in the 
program.  
A special thank you to Dr. Claude Mallet and Waters Corporation for the 
collaboration and internship experience that gave me the space to complete my research. 
Thank you to my other committee member Joshua Wilhide for providing assistance 
remotely. 
To my parents, friends, family, and Ian Miller, I cannot thank you enough for your 
love and support throughout this entire process. Without you this would not be possible. 
Thank you for your words of encouragement, tough love, and for keeping me sane during 




UTILIZATION OF A DERIVATIZATION METHOD WITH 
MULTIDIMENSIONAL LIQUID CHROMATOGRAPHY-MASS 
SPECTROMETRY FOR THE DETECTION OF NEUROTRANSMITTERS 
 
 
OLIVIA KAYE GEORGE 
 
ABSTRACT 
Neurotransmitters are endogenous compounds located in the brain and can occur in 
other parts of the body at low concentrations. They are a challenging group of compounds 
when it comes to analysis. Compounds with amine functionality such as dopamine and 
serotonin are sensitive to high pH and light and can spontaneously oxidize and degrade. 
Since neurotransmitters exist at low levels, it can be difficult to achieve sufficient 
spectrometry data and clean chromatography.  In order to improve data acquisition, 
derivatization and the use of  multidimensional liquid chromatography (2D-LC) was 
evaluated.  Dopamine, L-3,4-dihydroxyphenylalanine (L-DOPA), serotonin, tyrosine, 
tryptophan, and noradrenaline were the compounds of interest with tyramine included as 
an internal standard.  Data was collected before and after derivatization to compare the 
resulting chromatography. Chromatography was completed using a 6x6 grid of methods 
with variables of organic solvent, elution pH, loading pH, and trapping column chemistry 
utilizing different elution column chemistries. Derivatization was examined with Dabsyl-
Cl and Dansyl-Cl at pH 8.5, 9.5, 10.5, and 14. A final method was chosen with Dabsyl at 
pH 8.5 for the Multiple Reaction Monitoring (MRM) scans. Before derivatization, the 
chromatography had poor peak shapes such as tailing, fronting, or shouldering or too much 
vi 
distortion to be able to distinguish a peak for all of the examined methods.  Resulting 
chromatography after derivatization showed overall improvement in peak shape and 
intensity for a majority of the methods.  Derivatization aided in increasing the mass and 
stability of the compounds which allowed for more sensitive detection. Multidimensional 
liquid chromatography improved the separation of structurally similar compounds and 
increased sensitivity. By combining the two, better analysis of neurotransmitters was 
possible. 
vii 
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 Neurotransmitters and their effects have been a popular point of study in a variety 
of fields from neuroscience and psychology to forensics and pharmacology [1].  Their 
prevalence in recent scientific literature has increased in parallel with the understanding of 
the brain.  The best approach to starting analysis is to understand their function and roles 
inside of the body. Neurotransmitters are endogenous compounds located in the brain and 
can occur in other parts of the body at low concentrations [1].  The release of 
neurotransmitters is facilitated by electrochemical pathways that signal neurons to fire.  
The pre-synaptic neuron forms an envelope around the neurotransmitter called a vesicular 
neurotransmitter transporter (VNT).  The VNT binds to the outside edge of the neuron and 
releases the neurotransmitter into the synaptic cleft.  The neurotransmitter is received by 
the plasma membrane neurotransmitter transporter (PMNT).  Each PMNT is designed to 
fit a specific neurotransmitter based on its structure [3].  Once received, the 
neurotransmitter is released into the post-synaptic neuron [2, 3].  The transmission of the 
compounds is vital for aiding specific brain functions whether related to hormones or 
peripheral body functions [4, 5].  Dopamine, for instance, is related to motivation, 
cardiovascular activities, motor function, and the balance of mood.  Serotonin levels are 
connected to sleep cycles, sensory perception, mood, appetite, and sexual motivation [4- 
6].   Much like the affinity of the PMNTs, neurotransmitters are classified by their structure.  
Classifications include amino acids such as glutamate and GABA, amines or 
2 
catecholamines like norepinephrine and dopamine, and peptides such as oxytocin and 
vasopressin  [1, 5]. The experiment discussed here focuses on the analysis of amines: 
dopamine, L-3,4-dihydroxyphenylalanine (L-DOPA), serotonin, noradrenaline, tyrosine, 
and tryptophan with tyramine as an internal standard. Each compound has either a primary 
or secondary amine functional group attached on the carbon chain connected to an aromatic 
structure (Figure 1). 
 
Figure 1. Chemical structure of analyzed neurotransmitters [37-43]. 
 Regulation of neurotransmitters within the body is important for maintaining a state 
of homeostasis and ensuring that all functions are normal.  Disfunction in the reuptake or 
metabolism of neurotransmitters can either cause the brain to produce too much or too 
little.  Inhibitors prevent the reuptake and will signal as if there is nothing present, therefore 
causing an overproduction of a specific neurotransmitter [3]. Additional abnormalities in 
the synaptic cleft and use of drugs of abuse can also cause overproduction as well as 
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underproduction. [3, 7] The dysregulation can lead to a wide range of physical and mental 
disorders such as depression, schizophrenia, Tourette’s Syndrome, bipolar disorder, 
attention deficit hyperactive disorder (ADHD), Parkinson’s, addiction, and hypertension 
[8-12].  Some studies show that higher serotonin levels are also seen in patients with 
metastatic carcinoid tumors [13].  
 
Forensic Relevance 
 As mentioned above, drugs of abuse can have a significant impact on the 
concentration of neurotransmitters in the brain.  They can extend the release especially if 
their structures are similar to endogenous compounds.  The similar structure allows for less 
secure bonding on the PMNTs and disruption of the reuptake of the neurotransmitter for 
which it was designated [1].  Prescription drugs for neurological disorders also have an 
influence on regulation.  In most cases the prescribed medication is responsible for 
facilitating the increase of neurotransmitter production. However, some exist to decrease 
the production such as in cases of ADHD and schizophrenia [22]. Both prescribed and 
illicit drugs can be detected in cases of drug abuse, emergency toxicological screenings, 
and forensic medical examinations [2]. Other examinations will measure the 
neurotransmitter levels directly, but complications occur when attempting to decipher 
whether the source of the neurotransmitter is endogenous or from an external source.  Some 
studies have examined the connection of neurotransmitters to levels of aggression 
especially in criminal cases due to the influence on reward mechanisms, risk taking, and 
mood.  Consideration of neurotransmitter levels have been taken into account in forensic 
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examinations for pursuing an insanity plea.  While mental disorders and dysfunction can 
be related to the commission of crimes, other external factors such as childhood trauma, 
family dynamics, and peer relations also have a prominent influence [14]. 
 
Challenges with Analysis 
 Analysis of neurotransmitters can be quite challenging due to their inherent 
chemical and physical properties.  Several compounds such as dopamine and noradrenaline 
have sensitivity to light and high pH which can cause degradation [1].  Both compounds 
also undergo spontaneous oxidation under certain conditions and have multiple pKa values 
that gives them zwitter ionic behavior.  [1].  Most neurotransmitters will occur at low levels 
which requires lower detection limits. The limitation is partially due to metabolism 
degradation as well as matrix effects and ion suppression [4].  Due to the presence of 
endogenous levels, analysis can be difficult when trying to determine whether or not the 
presence is from an outside source [2].  Current analytical methods are lacking in levels of 
detection which is an issue when examining a compound at levels lower than 0.57 pmol/mL 
[22] and means to compensate for the zwitter ionic behavior. Some compounds also have 
similar structures to each other and will elute at similar times.  To compensate, scientists 
have developed methods with lengthy run times and intensive sample preparation hoping 
to improve separation. Additionally, they use reversed phase separation which has 
difficulty when the compounds have multiple pKa values. [5, 10, 15]. The issue can be 




 One approach for the analytical challenges mentioned is through the use of 
derivatization.  Derivatization is the alteration of the chemical structure of a compound to 
increase its utility in analysis.  The transformation into a derivative product is dependent 
on the selection of a derivatization agent [16, 17].  An agent is chosen based on its structure 
and its ability to bind to specific functional groups.  Binding can provide additional means 
of detection such as fluorescence, isotopic tagging, or increased tandem mass spectrometry 
(MS/MS) fragmentation signatures.  Derivatization can increase stability and improve 
chromatography to aid in identification and quantitation.  The improvement can be seen in 
signal enhancement as well as increased separation [16-18].  In the following experiments, 
considerations were given to derivatization agents that were able to bond to amine or 
phenol functionality. Studies on amines have examined the use of Dansyl-Cl [18-22], 
Dabsyl-Cl [18, 23], FMOC-Cl [18, 19, 23. 24], OPA [18, 25], Marfey’s reagent [18], 
diethyl ethoxymethylenemalonate [23], and butanol [19]. Studies with on phenol 
applications focused on Dansyl-Cl [26], Dabsyl-Cl [21], and azo coupling reactions [27]. 
Due to their applications for both amines and aromatics, Dabsyl-Cl and Dansyl-Cl were 
selected. FMOC-Cl was also selected as means of having an increased focus on the amine 
functionality of the neurotransmitters.  A few analytical methods were considered based 
on previous literature: liquid chromatography-mass spectrometry (LC-MS) and liquid 
chromatography-tandem mass spectrometry (LC-MS/MS) [18, 28]. Multidimensional 
high-performance liquid chromatography mass spectrometry (2D-HPLC-MS) has little to 
6 
no research regarding its validity for neurotransmitter applications and was chosen to be 
evaluated.  
 
Multidimensional High-Performance Liquid Chromatography 
 Multidimensional high-performance liquid chromatography is liquid 
chromatography that combines multiple pumps in various configurations. Simpler 
configurations may only use two or three pumps, but more complex setups can use as many 
as six [30, 31].  The configuration for the experiment makes use of a three-pump design as 
seen in Figure 2.  Two quaternary pumps, also called quaternary solvent managers (QSMs), 
act as the loader and diluter. A single binary pump, or binary solvent manager (BSM), is 
used to elute.  Each dimension is designated as Dimension 1 (D1) and Dimension 2 (D2). 
The sample is trapped in the first dimension and eluted and separated in the second 
dimension with the aid of the eluter pump.  
 
Figure 2. 2D-HPLC pump configuration with three pumps [30]. 
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Multidimensional high-performance liquid chromatography is ideal for analysis due to its 
ability to be flexible in its configurations and the inclusion of an option to inject a large 
volume without distorting the peak shape due to backflush elution. [32, 33]. The increased 
number of pumps work in conjunction with using two dimensions to achieve 
chromatographic separation.  The trapping dimension contains a large particle size which 
contains the target analyte within a narrow band.  A second dimension contains smaller 
particles and utilizes back flush elution to move the analyte through the system [33].  The 
exact particle sizes will vary depending on the compounds being analyzed.  By combining 
the two, the effect of breakthrough seen in large volume injection and the injection of high 
organic content is effectively eliminated [35].  The process decreases the need for long 
sample preparation by eliminating the need for an evaporation step in the extraction method 
[19, 35].  Separation, resolution, and limit of detection can be improved by altering the 
loading, trapping and eluting conditions to include different solvents at various pH values. 
Additional alterations are available such as changing the column chemistry can have a 
significant effects based on the sample’s affinity to the column’s specific functional group. 
The following experiment utilizes acetonitrile and methanol at pH 3 and 10 as well as 
aqueous phase at pH 3, 7, and 10 as the solvents.  Several column chemistries included in 
the experiment are C8 and HLB for trapping and C18, BEH Phenyl, and HSS T3 for 
elution.  The parameters listed were chosen for their frequency of use in laboratory settings 
as well as overall effectiveness for a variety of samples.  With optimization of the 2D 
method, high precision and accuracy can be achieved as well as increased limit of detection 
and specificity [20, 21]. However, 2D-LC can be more expensive than traditional LC 
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methods and is seen as too complex for first-time users [30]. With adequate training the 
method is more accessible for those with little to no experience. The ability to have shorter 
run times increases the throughput and productivity of the instrument which can offset 
initial costs [30]. The benefits of multidimensional liquid chromatography make it ideal 
for the analysis of neurotransmitters and allows for the compounds to have a higher 
likelihood of being detected. The experiments described below seek to determine if 
chromatographic separation improves by combining the effects of derivatization and 
multidimensional liquid chromatography.  If chromatography does improve, then pairing 
the two methods together could be a viable way of improving detection of 
neurotransmitters.  
9 
MATERIALS AND METHODS 
Chemicals 
Standards 
 Standards of dopamine, L-DOPA, serotonin, noradrenaline, tyrosine, tryptophan, 
and tyramine were obtained from Sigma-Aldrich (St. Louis, Missouri, USA).  A stock 
solution of each standard compound was made at 1.0 mg/mL in 80:20 acetonitrile (ACN) 
to water by measuring 10-20 mg of solid standard in a 20 mL glass vial and adding the 
corresponding amounts of ACN and water.  If the solution was not completely dissolved, 
100 μL portions of concentrated HCl were added until completely dissolved and aided by 
sonication if necessary.  Additional dilutions were completed in water, ACN, and MeOH 
separately to have standards at 1.0 μg/mL (1 ppm) and 1.0 ng/mL (1 ppb).  
 
Mobile Phase 
 HPLC-grade ACN and MeOH were purchase from Fisher Scientific (Pittsburg, 
Pennsylvania, USA).  Organic and aqueous elution mobile phases were prepared by the 
addition of 0.5% FA in 2.0 L for low pH (pH 3) solutions and 0.5% NH2OH in 2.0 L  for 
high pH (pH 10) solutions. Loading mobile phase was prepared as aqueous solutions at pH 
3 (2% FA), pH 7 (no buffer), and pH 10 (2% NH2OH) in 5.0 L.  Additional organic (MeOH) 
and aqueous mobile phase was made with 0.5% NH4F in 2.0 L and 0.5% ammonium 





 Standards of Dansyl-Cl, Dabsyl-Cl, and FMOC-Cl were obtained from Sigma-
Aldrich (St. Louis, Missouri, USA) and diluted to 1.0 mg/mL in ACN.  Glycine was also 
obtained from Sigma and diluted to 0.1 mg/mL in deionized water.  Buffers for the 
derivatization process were mixed in ACN (boric acid – pH 8.5, sodium borate –  pH 9.5, 
sodium bicarbonate – pH 10.5, NaOH – pH 14).  HPLC grade acetone and ethyl acetate 




 LC analysis was completed on a Waters Acquity UPLC Class system (Milford, 
Massachusetts, USA)  in a two-dimensional configuration with two quaternary solvent 
managers (QSMs) used for loading and dilution, one binary solvent manager (BSM) used 
for elution, autosampler, and column manager.  Two columns were examined for trapping: 
Waters Acquity UPLC C8 (2.1mm x 30mm, 10 μm bead size) and Waters Acquity HLB 
(2.1mm x 30mm, 20 μm bead size).  Three columns were examined for elution: Waters 
Acquity HSS T3 (2.1mm x 100mm, 1.7 μm bead size), Waters Acquity UPLC BEH C18 
(2.1mm x 100mm, 1.7 μm bead size), and Waters Acquity BEH Phenyl (2.1mm x 100mm, 
1.7 μm bead size).  Injection volume was 20 μL.  Dilution flow rate was set at 2.0 ml/min 
and loading flow rate at 0.1 mL/min.  Elution occurred at 0.5 ml/min with the organic 
gradient as follows: 0-3 min (5% B), 3-8 min (5% to 95% B), 8-9 min (95% B), 9-9.5 min 
(95% to 5% B), 9.5-10 min (5% B).  
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MS Setup 
 MS analysis was completed on a Waters Acquity UPLC Class system connected to 
a Waters Xevo TQ-S with Intellistart (Milford, Massachusetts, USA) set in positive ESI 
mode. Capillary voltage was set at 3.0 kV, cone voltage at 30 V, and source offset at 60V 
determined offline. Desolvation temperature was set at 450oC and desolvation flow at 1100 
L/hr. Cone flow was set at 150 L/hr. 
 
Derivatization Process 
 Before starting the process, a mixture of the neurotransmitters was made and was 
diluted in acetonitrile to a final concentration of 1.0 μg/mL.  Derivatization with each 
compound (Dabsyl-Cl, Dansyl-Cl, FMOC-Cl) was completed as follows. In a glass tube 
800 μL of deionized water was added followed by 580 μL of one organic solvent (ACN, 
acetone, or ethyl acetate).  Then 200 μL of buffer (boric acid – pH 8.5, sodium borate –  
pH 9.5, sodium bicarbonate – pH 10.5, NaOH – pH 14) was introduced to maintain the pH 
of the reaction.  200 μL of the neurotransmitter mix (1.0 μg/mL) was added. Finally, 20 μL 
of the derivatization compound (1.0 mg/mL) was added.  Each vial was topped with 
aluminum foil and vortexed for three to five seconds then heated at 60o C for thirty minutes.  
Once removed the heat, the aluminum foil was removed and 200 μL of glycine at 0.1 
mg/mL.  For this project samples were made containing each combination of derivatization 
compound, buffer pH, and organic solvent.  
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RESULTS AND DISCUSSION 
 
Underivatized Compounds 
 The analysis of neurotransmitters was first completed by examining the data before 
derivatization. It would determine the overall baseline. Once the data for spectrometry and 
chromatography was collected, a decision needed to be reached as to whether or not the 
derivatization process would be required. 
 
Spectrometry Data 
 Mass spectrometry data was collected to selected and optimize two multiple 
reaction monitoring (MRM) transitions for quantification and confirmation using a process 
adapted from several studies utilizing 2D technology [15, 32, 33, 35, 36].  Due to the use 
of ESI+ ionization mode, each neurotransmitter was protonated, and the resulting ions are 
in their [M+H]+ state.  Precursor ions were determined by infusion using MS scan mode at 
pH 3, 7, and 10.  Each scan was captured to confirm the presence of the specific 
neurotransmitter and later focused on the apex of the peak to determine the decimal value. 
In the resulting scan for dopamine (Figure 3), the protonated mass of 154 was seen at pH 
3 and 7 but is not shown at pH 10.  Scans for L-DOPA in Figure 4 show similar difficulties 
with the ion of m/z 197 or 198 only appearing at pH 3 and 7.  Both sets of scans for 
serotonin (Figure 5) and tyrosine (Figure 6) show peaks for their respective ions, m/z 177 




Figure 3. MS Scan of underivatized dopamine at pH 3, 7, and 10. 
 
Figure 4. MS Scan of underivatized L-DOPA at pH 3, 7, And 10. 
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Figure 5. MS Scan of underivatized serotonin at pH 3, 7, and 10.  
 
Figure 6. MS Scan of underivatized tyrosine at pH 3, 7, and 10. 
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Scans of tryptophan (Figure 7) show intense peaks at the desired ion value of m/z 
205, but also shows significant peaks at 188 m/z  [M-H2O] for all three pH values and at 
m/z 226 [M+Na] at pH 10.  Each of the other neurotransmitters analyzed in the experiment 
do not correlate to the foreign ion values and can be eliminated as the reason for the peaks.  
Noradrenaline was the most difficult neurotransmitter for the MS scan to detect.  Figure 8 
shows the desired ion of m/z 171 at pH 3 and 7, but the peaks are weak compared to peaks 
around m/z 420 and 425 which could be carryover from a previous sample.   
 
Figure 7. MS Scan of underivatized tryptophan at pH 3, 7, and 10. 
16 
 
Figure 8. MS Scan of underivatized noradrenaline at pH 3, 7, and 10. 
 
 Once the precursor ions were determined, the next step was to determine the 
product ion values and their respective collision induced dissociation (CID) energy values.  
Production of product ions was completed using infusion under MS/MS scan mode with 
acquisitions at each CID increasing the value by five each time.  CID was raised until the 
precursor ion peak disappeared.  The highest CID level for this portion was 25 or 30 
depending on the neurotransmitter. Spectra only show values of CID 5 to CID 25.  Once 
each spectra was acquired, the two most prominent peaks were selected as product ions 
and their corresponding CID value was determined when the ions were at the highest 
intensity.  Analysis of the apex of individual peaks at the selected CID value determined 
the decimal value. Resulting values of MS and MS/MS scans can be seen in Table 1.  
Selected CID values were 25 or lower which shows that underivatized neurotransmitters 









Figure 10. MS/MS scans of tryptophan and noradrenaline from CID 5 to CID 25. 
 
Table 1. MRMs - Precursor and product ion values and corresponding CID energy values. 
Neurotransmitter Precursor Ion Product Ion 1 CID 1 Product Ion 2 CID 2 
Dopamine 154.5 137.1 10 91.1 20 
L-DOPA 198.2 152.1 10 107.1 20 
Serotonin 177.2 160.1 20 142.2 20 
Tyrosine 182.1 136.2 10 91.1 25 
Tryptophan 205.2 146.1 15 118.1 25 






 Once the MRMs were developed, the next step was to determine the quality of 
chromatography for each neurotransmitter. The goal was to optimize different parameters 
on both dimensions. The first dimension has a focus on the retention strength of the trap 
column as well as the loading pH to effectively retain the sample in a narrow band. For the 
second dimension the priority is elution which relies on the pH and polarity of the elution 
solvent. There are a wide variety of potential options for each parameter, but the number 
of combinations would be too large for the scope of the project. To keep the process 
streamlined, the first dimension was limited to the three most common loading pHs and 
trap column chemistries. The second dimension focused on two elution pHs and two 
elution solvents. Each combination is displayed in a 6x6 grid format shown in Figure 11 
and the corresponding method number.   Initial tests of the C18 trap column gave 
unreadable signal and was further omitted from the study.  Analysis was completed using 
20 μL injections of a 1.0 μg/mL mix of all of the neurotransmitters. 
 
Figure 11. 6x6 grid with 36 methods for optimization. 
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 Results of the 6x6 grid methods for each elution column are shown in Figures 13-
17.  Each neurotransmitter was prepared in water, ACN, or MeOH in preparation for  
potential use with solid phase extraction (SPE).  The three colors represent the quality of 
chromatography.  Green indicates that the resulting peak was Gaussian in shape and notes 
the corresponding intensity of the peak as well as the presence of multiple peaks (MP).  
Yellow implies peak distortion and notes the appearance of the distortion such as broad, 
tailing, fronting, shouldering, or split peaks.  Red denotes that the peak is indistinguishable 
either from noise or the overall chromatogram is too distorted.  Examples of each color can 
been seen in Figure 12.  Within the grid results, it can be seen that the majority of resulting 
chromatograms fell into the red or yellow category for all of the elution columns.  The 
BEH C18 column with a pH 10 elution in ACN showed the largest number of green boxes 
overall, but across the board noradrenaline and serotonin could not be distinguished using 
this method.   
 




Figure 13. 6x6 grid results HSS T3 elution. High pH elution for ACN (method 10-18) and MeOH 
(method 28-36) were not processed due to time constraints. 
HSS T3  ACN pH 3 elution










Tyrosine (Water) e5 MP e5 MP
Tyrosine (ACN) e5 MP e5 MP
Tyrosine (MeOH) e5 MP e5 MP
L-DOPA (Water) e5 e5
L-DOPA (ACN) e5 e5
L-DOPA (MeOH) e6 e6
Tryptophan (Water) broad broad broad broad
Tryptophan (ACN) broad broad broad broad
Tryptophan (MeOH) broad broad broad broad
HSS T3  MeOH  pH 3 elution






















Figure 14. 6x6 grid results BEH C18 ACN elution. 
BEH C18 ACN pH 3 elution
1 2 3 4 5 6 7 8 9
Dopamine (Water) e5 broad
Dopamine (ACN) e5 broad




Serotonin (Water) broad broad
Serotonin (ACN) broad broad




L-DOPA (Water) e5 e5
L-DOPA (ACN) e5 e5
L-DOPA (MeOH) e5 e5
Tryptophan (Water) broad broad
Tryptophan (ACN) broad broad
Tryptophan (MeOH) broad broad
BEH C18 ACN pH 10 elution
10 11 12 13 14 15 16 17 18
Dopamine (Water) e5 e7 e6 e6
Dopamine (ACN) e5 e6 e6 e6







Tyrosine (Water) e6 e6 e7 e6 e6
Tyrosine (ACN) e6 e6 e7 e6 e6
Tyrosine (MeOH) e6 e6 e7 e6 e6
L-DOPA (Water) e5 e5 e5 e5 e5
L-DOPA (ACN) e5 e5 e5 e5 e5
L-DOPA (MeOH) e5 e5 e5 e5 e5
Tryptophan (Water) e7 e8 e7 e8 e7 e6
Tryptophan (ACN) e7 e8 e7 e8 e7 e6




Figure 15. 6x6 grid results BEH C18 MeOH elution pH 3 and 10.  
BEH C18 MeOH pH 3 elution
19 20 21 22 23 24 25 26 27
Dopamine (Water) e6 broad e6 broad
Dopamine (ACN) e6 broad e6 broad




Serotonin (Water) broad broad
Serotonin (ACN) broad broad







Tryptophan (Water) broad broad broad
Tryptophan (ACN) broad broad broad
Tryptophan (MeOH) broad broad broad







Serotonin (Water) broad e6 broad
Serotonin (ACN) broad e6 broad







Tryptophan (Water) e6 broad e5 broad e5 broad
Tryptophan (ACN) e6 broad e5 broad e5 broad




Figure 16. 6x6 grid results BEH C18 MeOH elution NH4F and Ammonium bicarbonate. 
BEH C18 MeOH NH4F elution










Tyrosine (Water) e5 e5
Tyrosine (ACN) e5 e5







BEH C18 MeOH NH4Bicarbonate elution













L-DOPA (Water) e5 e5
L-DOPA (ACN) e5 e5







Figure 17. 6x6 grid results BEH Phenyl MeOH elution NH4F and Ammonium bicarbonate. 
 
 
BEH Phenyl MeOH NH4F elution










Tyrosine (Water) e5 e5
Tyrosine (ACN) e5 e5







BEH Phenyl MeOH NH4Bicarbonate elution





















 Due to poor chromatography of the underivatized samples and testing of each 
variable, the choice was made to explore the option of modifying the structure to add some 
hydrophobicity to the molecule. The modification would be done through the process of 
derivatization. For the derivatization, three agents were selected: Dabsyl-Cl, Dansyl-Cl, 
and FMOC-Cl. Initial testing of the FMOC-Cl solution showed no change in the overall 
quality of the chromatography and was dismissed as a potential derivative. Therefore, the 
focus was shifted onto the other two compounds.  
 
Selection of Method 
Once Dabsyl-Cl and Dansyl-Cl were selected, preparation of the standards were 
made at 1 mg/mL in ACN.  Since the literature explained that Dabsyl-Cl and Dansyl-Cl 
could interact with phenols and amine functional groups, an initial examination was done 
to determine where on the molecule the derivatization agent would attach [18-23].  It was 
found that the agents would bind to primary and secondary amines through the loss of Cl 
on the agent and H+ from the amine.  Structure of each agent and example binding locations 
are shown in Figure 18.  The derivatization process was developed by adapting several 
previous studies that included the use of buffers at pH 8.5, 9.5, and 10.5 [18, 22, 26]. Since 
dopamine and other neurotransmitters are sensitive to high pH, another buffer of pH 14 
was included. Tyramine, a compound structurally similar to dopamine, was included in the 











 Spectrometric data was collected in LC/MS mode instead of infusion as the 
concentration of the analytes were too low to be seen. Scans were collected to determine 
the precursor ion followed by Selected Ion Recording (SIR) scans to determine the decimal 
value. Initial precursor values for Dabsyl and Dansyl are shown in Table 2.  SIR scans were 
taken between 2 amu above and below the calculated value in 0.5 amu increments.  Product 
ions were determined by daughter scans taken at the SIR value with the highest intensity 
and one increment above.  The final SIR value was determined by the one with the most 
intense product ions.  SIR scans for Dabsyl are shown in Figures 19 and 20 and 
corresponding daughter scans are in Figure 21 and 22. Dansyl SIR scans are in Figure 23 
and 24 and daughter scans are in Figure 25 and 26. 
 





MW of Derivatized 
Compound (Dabsyl) 
MW of Derivatized 
Compound (Dansyl) 
Dopamine 153.2 440.9 386.9 
L-DOPA 197.2 484.9 430.9 
Serotonin 176.2 463.9 409.9 
Tyrosine 181.2 468.9 414.9 
Tryptophan 204.2 491.9 437.9 
Noradrenaline 169.2 456.9 402.9 




Figure 19. Dabsyl SIR scans for dopamine, L-DOPA, serotonin, and tyrosine. 
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Figure 20. Dabsyl SIR scans for tryptophan, noradrenaline, and tyramine. 
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Figure 21. Dabsyl Product Ion scans for dopamine, L-DOPA, Serotonin, and tyrosine. 
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Figure 22. Dabsyl Product Ion scans for tryptophan, noradrenaline, and tyramine. 
33 
 Once product ion scans were acquired, the ion values were used to create MRMs 
(Table 3 and 4).  Each ion was analyzed individually to determine which would be the 
quantitative and qualitative transition.  One major difference seen here in comparison to 
the underivatized compounds was that the ion values were almost identical for all 
compounds in both derivatization methods when run on the same day.  Additionally, the 
average CID value was much higher with a minimum of CID 20.  As the compounds were 
much larger with the addition of the derivatization agent, it would be logical to assume 
more energy is needed to cause fragmentation.   
 












Dopamine 439.5 225.3 25 75.5 40 
L-DOPA 485.0 225.3 25 75.6 45 
Serotonin 464.5 224.2 25 120.0 40 
Tyrosine 469.5 225.2 30 119.9 40 
Tryptophan 492.5 224.1 20 120.0 40 
Noradrenaline 457.5 225.3 20 75.6 45 










Figure 24. Dansyl SIR scans for tryptophan, noradrenaline, and tyramine. 
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Figure 26. Dansyl Product Ion scans for tryptophan, noradrenaline, and tyramine. 
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Dopamine 387.0 170.1 25 156.0 40 
L-DOPA 431.0 171.1 45 156.1 45 
Serotonin 410.5 160.0 20 146.1 35 
Tyrosine 415.5 170.0 20 106.8 30 
Tryptophan 438.5 170.1 30 130.0 40 
Noradrenaline 403.5 171.1 25 156.0 40 
Tyramine 371.5 156.1 35 249.3 25 
 
Chromatography Data 
 Once the MRM value were determined, a derivatization method was selected based 
on the chromatography.  Initial tests were run for both Dabsyl-Cl and Dansyl-Cl at pH 8.5, 
9.5, 10.5, and 14.  Chromatograms for each neurotransmitter created with each method 
were compared to see which would give the best overall peak shapes and highest intensity. 
An example using tryptophan can be seen in Figure 27.  Overall, it was decided that Dabsyl 
at pH 8.5 would be the best choice.  Further testing could be done at pH 9.5 to compare the 
chromatographic results.  After the method was decided, the neurotransmitter mix was 
derivatized accordingly and analyzed under the same conditions as the underivatized 
compound except that samples were prepared in acetone and ethyl acetate instead of water 
and methanol.  Results of the 6x6 grid methods can be seen in Figure 28-33.  
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Figure 27. MRM chromatograms for tryptophan under DAN and DAB derivatizations at pH 




Figure 28. 6x6 grid results HSS T3 elution derivatized. 
HSS T3  ACN pH 3 elution
1 2 3 4 5 6 7 8 9
Dopamine (ACN) e5 e5 e4 e4 e5 MP low sig
Dopamine (Ace) e5 e5 e4 e4 e5 MP low sig
Dopamine (EA) e5 e5 e4 e4 e5 MP
Noradrenaline (ACN) low sig low sig
Noradrenaline (Ace) e5 low sig
Noradrenaline (EA) low sig low sig
Serotonin (ACN) e5 broad e5 e5 e5 e5 MP
Serotonin (Ace) e5 broad e5 e5 e5 e5 MP
Serotonin (EA) e5 broad e5 e5 e5 e5 MP
Tyrosine (ACN) e6 MP e6 MP e6 MP e6 MP e6 MP e6 MP
Tyrosine (Ace) e6 MP e6 MP e6 MP e6 MP e6 MP e6 MP
Tyrosine (EA) e6 MP e6 MP e6 MP e6 MP e6 MP e6 MP
L-DOPA (ACN) e4 MP broad e4 MP e4 low sig low sig
L-DOPA (Ace) e4 MP broad low sig e4 low sig low sig
L-DOPA (EA) e4 MP broad e4 MP e4 low sig low sig
Tryptophan (ACN) e6 e6 e6 e6 e7 tailing
Tryptophan (Ace) e7 e6 e6 e6 e7 tailing
Tryptophan (EA) e7 e6 e6 e6 e7 tailing
5-hydroxytryptophan (ACN) e6 e5 e5 e5 e6 tailing
5-hydroxytryptophan (Ace) e6 e5 e5 e5 e6 tailing
5-hydroxytryptophan(EA) e6 e6 e5 e5 e6 tailing
Tyramine (ACN) e6 MP e6 MP e6 MP e6 MP e7 MP tailing
Tyramine (Ace) e6 MP e6 MP e6 MP e6 MP e7 MP tailing
Tyramine (EA) e7 MP e6 MP e6 MP e6 MP e7 MP tailing
HSS T3  MeOH pH 3elution
19 20 21 22 23 24 25 26 27
Dopamine (ACN) e5 e4 low sig
Dopamine (Ace) e6 e5 e5
Dopamine (EA) e5 e5 low sig
Noradrenaline (ACN) low sig
Noradrenaline (Ace) low sig
Noradrenaline (EA) low sig
Serotonin (ACN) e6 tailing e6
Serotonin (Ace) e6 tailing e6
Serotonin (EA) e6 tailing e6
Tyrosine (ACN) e6 MP tailing e6 MP
Tyrosine (Ace) e6 MP tailing e6 MP
Tyrosine (EA) e6 MP tailing e6 MP
L-DOPA (ACN) e5 MP tailing e5 MP
L-DOPA (Ace) e5 MP tailing e5 MP
L-DOPA (EA) e5 MP tailing e5 MP
Tryptophan (ACN) e7 tailing e7
Tryptophan (Ace) e7 tailing e7
Tryptophan (EA) e7 tailing e7
5-hydroxytryptophan (ACN) e6 tailing e6
5-hydroxytryptophan (Ace) e6 tailing e6
5-hydroxytryptophan(EA) e6 tailing e6
Tyramine (ACN) e7 MP tailing e6
Tyramine (Ace) e7 MP tailing e7 MP




Figure 29. 6x6 grid results BEH C18 ACN elution derivatized. 
BEH C18 ACN pH 3 elution
1 2 3 4 5 6 7 8 9
Dopamine (ACN) e5 tailing e5 e5 e5 low sig
Dopamine (Ace) e5 tailing e5 e5 e5 MP low sig
Dopamine (EA) e5 tailing e5 e5 e5 MP low sig
Noradrenaline (ACN) e5 MP e5 low sig e5 low sig e5 MP
Noradrenaline (Ace) e5 MP e5 e5 MP e5 e5 MP e5 MP
Noradrenaline (EA) e5 MP e5 low sig e5 e5 MP e5
Serotonin (ACN) e6 MP tailing e5 tailing e6 tailing
Serotonin (Ace) e5 MP tailing e5 tailing e5 MP tailing
Serotonin (EA) e5 tailing e5 tailing e5 MP tailing
Tyrosine (ACN) split tailing e6 tailing e6 tailing
Tyrosine (Ace) split tailing e6 tailing e6 tailing
Tyrosine (EA) e6 MP tailing e6 tailing e6 tailing
L-DOPA (ACN) e5 MP tailing low sig tailing e5
L-DOPA (Ace) e5 MP low sig e5 MP low sig e5 low sig
L-DOPA (EA) e5 tailing e5 tailing e5
Tryptophan (ACN) e7 tailing e6 tailing e7 tailing
Tryptophan (Ace) e7 tailing e7 tailing e7 tailing
Tryptophan (EA) e7 tailing e7 tailing e7 tailing
5-hydroxytryptophan (ACN) e6 MP tailing e6 MP tailing e6 tailing
5-hydroxytryptophan (Ace) e6 MP tailing e6 tailing e6 tailing
5-hydroxytryptophan(EA) e6 MP tailing e6 tailing e6 tailing
Tyramine (ACN) e7 MP tailing e6 MP tailing e7 MP tailing
Tyramine (Ace) e6 MP tailing e7 MP tailing e7 MP tailing
Tyramine (EA) e7 MP tailing e7 MP tailing e7 MP tailing
BEH C18 ACN pH 10 elution
10 11 12 13 14 15 16 17 18
Dopamine (ACN) e5 MP tailing e5 e5 MP
Dopamine (Ace) e5 MP tailing e5 MP e5 MP
Dopamine (EA) e5 MP tailing e5 e5
Noradrenaline (ACN) e5 MP split e5 MP e6 e6 MP tailing
Noradrenaline (Ace) e5 MP split e6 e6 e6 tailing
Noradrenaline (EA) e5 MP split e6 MP e6 e6 MP tailing
Serotonin (ACN) e6 MP tailing e5 MP tailing e5 MP tailing
Serotonin (Ace) e6 MP tailing e5 MP tailing e5 MP tailing
Serotonin (EA) e6 MP tailing e5 MP tailing e5 MP tailing
Tyrosine (ACN) e7 MP e7 MP e7 MP e7 MP e7 MP e7 MP
Tyrosine (Ace) e7 MP e7 MP e7 MP e7 MP e7 MP e7 MP
Tyrosine (EA) e7 MP e7 MP e7 MP e7 MP e7 MP e7 MP
L-DOPA (ACN) e7 MP e7 MP e6 e6 MP e6 MP e7 MP
L-DOPA (Ace) e6 MP e6 MP e6 MP e5 MP e5 MP e5 MP
L-DOPA (EA) e7 MP e7 MP e6 e6 MP e6 MP e6 MP
Tryptophan (ACN) e8 e8 e8 e7 e8 e8
Tryptophan (Ace) e8 e8 e8 e7 e7 e7
Tryptophan (EA) e8 e8 e8 e8 e8 e8
5-hydroxytryptophan (ACN) e7 e7 MP e7 e7 e7 e7
5-hydroxytryptophan (Ace) e7 e7 MP e6 MP e6 MP e6 MP
5-hydroxytryptophan(EA) e7 MP e7 MP e7 MP e7 e7 e7
Tyramine (ACN) e8 MP tailing e7 MP tailing e7 MP tailing
Tyramine (Ace) e8 MP tailing e7 MP tailing e7 MP tailing




Figure 30. 6x6 grid results BEH C18 MeOH elution derivatized. 
BEH C18 MeOH pH 3 elution
19 20 21 22 23 24 25 26 27
Dopamine (ACN) e5 tailing e5 e5 e5
Dopamine (Ace) e5 tailing e5 e5 e5 MP low sig
Dopamine (EA) e5 tailing e5 e5 e5 MP low sig
Noradrenaline (ACN) e5 MP e5 MP e5 e5 low sig e5 MP
Noradrenaline (Ace) e5 MP e5 e5 e5 e5 MP e5 MP
Noradrenaline (EA) e5 MP e5 e5 e5 e5 e5 MP
Serotonin (ACN) e6 MP tailing e6 tailing e6 tailing
Serotonin (Ace) e5 tailing e5 tailing e5 MP tailing
Serotonin (EA) e5 tailing e5 tailing e5 MP tailing
Tyrosine (ACN) e6 MP tailing e6 tailing e6 tailing
Tyrosine (Ace) split tailing e6 tailing e6 MP tailing
Tyrosine (EA) split tailing e6 tailing e6 MP tailing
L-DOPA (ACN) e5 MP tailing e5 tailing e5
L-DOPA (Ace) e5 low sig e5 MP e5 MP
L-DOPA (EA) e5 tailing e5 tailing e5
Tryptophan (ACN) e7 tailing e7 tailing e7 tailing
Tryptophan (Ace) e7 tailing e7 tailing e7 tailing
Tryptophan (EA) e7 tailing e7 tailing e7 tailing
5-hydroxytryptophan (ACN) e6 tailing e6 tailing e6 tailing
5-hydroxytryptophan (Ace) e6 tailing e6 tailing e6 tailing
5-hydroxytryptophan(EA) e6 tailing e6 tailing e6 tailing
Tyramine (ACN) e7 tailing e6 MP tailing e7 MP tailing
Tyramine (Ace) e6 tailing e7 MP tailing e7 MP tailing
Tyramine (EA) e7 tailing e7 MP tailing e7 MP tailing
BEH C18 MeOH pH 10 elution
28 29 30 31 32 33 34 35 36
Dopamine (ACN) e5 MP
Dopamine (Ace) e5 MP
Dopamine (EA) e5 MP
Noradrenaline (ACN) e5 MP low sig fronting low sig low sig low sig
Noradrenaline (Ace) e5 MP low sig low sig low sig low sig
Noradrenaline (EA) e5 MP low sig fronting low sig low sig low sig
Serotonin (ACN) e6 MP tailing tailing low sig tailing low sig
Serotonin (Ace) e6 MP tailing tailing low sig tailing low sig
Serotonin (EA) e6 MP tailing tailing low sig tailing low sig
Tyrosine (ACN) e7 MP e5 MP e5 MP e5 MP e5 MP e5 MP
Tyrosine (Ace) e7 MP e5 MP e5 MP e5 MP e5 MP e5 MP
Tyrosine (EA) e7 MP e5 MP e5 MP e5 MP e5 MP e5 MP
L-DOPA (ACN) e7 MP low sig fronting low sig e5 e5
L-DOPA (Ace) e6 MP low sig low sig low sig low sig low sig
L-DOPA (EA) e7 MP low sig fronting low sig low sig e5
Tryptophan (ACN) e8 e6 e6 e5 e6 e6
Tryptophan (Ace) e8 e6 e6 e5 e6 e5
Tryptophan (EA) e8 e6 e6 e5 e6 e5
5-hydroxytryptophan (ACN) e7 e5 e6 e5 e5 e5
5-hydroxytryptophan (Ace) e7 e5 e6 e5 e5 e5
5-hydroxytryptophan(EA) e7 e5 e6 e5 e5 e5
Tyramine (ACN) e8 MP tailing tailing tailing tailing tailing
Tyramine (Ace) e8 MP tailing tailing tailing tailing tailing




Figure 31. 6x6 grid results BEH C18 MeOH elution derivatized NH4F and ammonium 
bicarbonate. 
BEH C18 MeOH NH4F elution
19 20 21 22 23 24 25 26 27
Dopamine (ACN) e5 MP low sig low sig tailing low sig
Dopamine (Ace) e5 e5 tailing tailing tailing low sig
Dopamine (EA) e5 MP e5 MP e5 MP e5
Noradrenaline (ACN) e5 MP e5 e5 MP e5 MP e5 MP
Noradrenaline (Ace) e5 MP e5 low sig e5 MP e5 MP e5 MP
Noradrenaline (EA) e5 MP e5 e5 MP e5 MP e5 MP e5 MP
Serotonin (ACN) tailing tailing tailing tailing tailing tailing
Serotonin (Ace) tailing tailing tailing tailing tailing tailing
Serotonin (EA) tailing tailing tailing tailing tailing tailing
Tyrosine (ACN) e6 MP e6 MP e6 MP e6 MP e6 MP e6 MP
Tyrosine (Ace) e6 MP e6 MP e6 MP e6 MP e6 MP e6 MP
Tyrosine (EA) e6 MP e6 MP e6 MP e6 MP e6 MP e6 MP
L-DOPA (ACN) tailing e5 e5 MP broad broad tailing
L-DOPA (Ace) tailing e5 MP e5 MP e5 MP tailing e5 MP
L-DOPA (EA) tailing e5 e5 MP broad broad tailing
Tryptophan (ACN) e7 e7 e7 e7 e7 MP e7
Tryptophan (Ace) e7 e7 e7 e7 e7 MP e7
Tryptophan (EA) e7 e7 e7 e7 e7 MP e7
5-hydroxytryptophan (ACN) e6 MP e6 MP tailing e6 MP tailing tailing
5-hydroxytryptophan (Ace) e6 MP e6 MP tailing e6 MP tailing tailing
5-hydroxytryptophan(EA) e6 MP e6 MP tailing e6 MP tailing tailing
Tyramine (ACN) e7 MP e7 e6 tailing e7 MP tailing
Tyramine (Ace) e7 e7 MP e7 MP tailing e7 MP tailing
Tyramine (EA) e7 e7 MP e7 MP tailing e7 MP tailing
BEH C18 MeOH NH4Bicarbonate elution




Noradrenaline (ACN) low sig fronting tailing low sig e4
Noradrenaline (Ace) low sig tailing low sig e4
Noradrenaline (EA) e5 fronting tailing low sig e4
Serotonin (ACN) tailing tailing tailing low sig tailing low sig 
Serotonin (Ace) tailing tailing tailing low sig tailing low sig 
Serotonin (EA) tailing tailing tailing low sig tailing low sig 
Tyrosine (ACN) e5 MP e5 MP e5 MP e5 MP e5 MP e5 MP
Tyrosine (Ace) e5 MP e5 MP e5 MP e5 MP e5 MP e5 MP
Tyrosine (EA) e5 MP e5 MP e5 MP e5 MP e5 MP e5 MP
L-DOPA (ACN) e5 e4 shoulder e4 e5 e5
L-DOPA (Ace) e5 MP e4 MP shoulder e4 e4 e4 MP
L-DOPA (EA) e6 e4 shoulder e4 e4 e5
Tryptophan (ACN) e6 e6 e6 e5 e6 e6
Tryptophan (Ace) e6 e6 e6 e5 e6 e5
Tryptophan (EA) e6 e6 e6 e5 e6 e5
5-hydroxytryptophan (ACN) e6 e5 e6 e5 e5 e5
5-hydroxytryptophan (Ace) e6 e5 e6 e5 e5 MP e5
5-hydroxytryptophan(EA) e6 e5 e6 e5 e5 MP e5
Tyramine (ACN) tailing tailing tailing tailing tailing tailing
Tyramine (Ace) tailing tailing tailing tailing tailing tailing




Figure 32. 6x6 grid results BEH Phenyl ACN elution derivatized. 
BEH Phenyl ACN pH 3 elution
1 2 3 4 5 6 7 8 9
Dopamine (ACN) e5 e5 MP e4 e4 MP e5 MP e4 MP
Dopamine (Ace) e5 e5 MP e5 MP e5 MP e5 MP e4 MP
Dopamine (EA) e5 e5 MP e5 MP e4 MP e5 MP e5 MP
Noradrenaline (ACN) e4 MP e4 MP e4 e4 MP e4 MP e4 MP
Noradrenaline (Ace) e4 MP e5 MP e4 MP e4 MP e4 MP e4 MP
Noradrenaline (EA) e4 MP e5 MP e4 MP e4 MP e4 MP e4 MP
Serotonin (ACN) e6 MP e6 e6 e6 e7 e6
Serotonin (Ace) e6 MP e6 MP e6 e6 e6 MP e6 MP
Serotonin (EA) e5 MP e5 MP e6 e6 e6 MP e6 MP
Tyrosine (ACN) e6 MP e6 MP e6 MP e6 MP e6 MP e6 MP
Tyrosine (Ace) e6 MP e6 MP e6 MP e6 MP e6 MP e6 MP
Tyrosine (EA) e6 MP e6 MP e6 MP e6 MP e6 MP e6 MP
L-DOPA (ACN) e5 MP e5 e5 e5 MP e5 e5
L-DOPA (Ace) e5 MP e5 MP e4 MP e4 MP low sig tailing
L-DOPA (EA) e5 MP e5 broad e5 MP e5 e5
Tryptophan (ACN) e6 e7 e7 e7 e7 e7
Tryptophan (Ace) e7 e7 e6 e6 e7 e7
Tryptophan (EA) e7 e7 e7 e7 e7 e7
5-hydroxytryptophan (ACN) e6 e6 e6 MP e6 MP e6 e6 
5-hydroxytryptophan (Ace) e6 e6 e6 MP e6 MP e6 MP e6 MP
5-hydroxytryptophan(EA) e6 e6 e6 MP e6 MP e6 MP e6 MP
Tyramine (ACN) e6 MP e7 MP e6 e6 e7 MP e7
Tyramine (Ace) e7 MP e7 MP e7 e7 e7 MP e7
Tyramine (EA) e7 MP e7 MP e7 e7 e7 MP e7
BEH Phenyl ACN pH 10 elution
10 11 12 13 14 15 16 17 18
Dopamine (ACN) e5 MP e5 MP low sig e5 MP e5 MP e5 MP
Dopamine (Ace) e5 MP e5 MP low sig low sig e5 MP e5 MP
Dopamine (EA) e5 MP e5 MP e5 MP e5 MP e6 MP e6 MP
Noradrenaline (ACN) e5 MP e5 MP e5 MP e5 MP e5 MP e5 MP
Noradrenaline (Ace) e5 MP e5 MP e5 MP e5 MP e5 MP e5 MP
Noradrenaline (EA) e5 MP e5 MP e5 MP e5 MP e6 MP e6 MP
Serotonin (ACN) e7 e7 e5 MP e5 MP e5 MP e5 MP
Serotonin (Ace) e6 MP e6 MP e5 MP e5 MP e5 MP e5 MP
Serotonin (EA) e6 MP e6 MP e5 MP e5 MP e5 MP e5 MP
Tyrosine (ACN) e7 MP e7 MP e6 MP e7 MP e7 MP e7 MP
Tyrosine (Ace) e7 MP e7 MP e7 MP e7 MP e7 MP e7 MP
Tyrosine (EA) e7 MP e7 MP e7 MP e7 MP e7 MP e7 MP
L-DOPA (ACN) e6 MP e6 MP tailing e6 MP e6 MP e6 
L-DOPA (Ace) e6 MP e6 MP e5 MP e5 MP e5 MP e5 MP
L-DOPA (EA) e6 MP e6 MP tailing e6 MP e6 MP e6 
Tryptophan (ACN) e8 e8 e7 e7 e7 e7
Tryptophan (Ace) e8 e8 e7 e7 e7 e7
Tryptophan (EA) e7 e7 e7 e7 e7 e7
5-hydroxytryptophan (ACN) e7 e7 e6 e7 e7 e7
5-hydroxytryptophan (Ace) e7 e7 e6 MP e6 MP e6 MP e6 MP
5-hydroxytryptophan(EA) e7 e7 e7 MP e7 MP e6 MP e7 MP
Tyramine (ACN) e7 MP e7 MP e7 e7 MP e7 MP e7 MP
Tyramine (Ace) e7 MP e7 MP e7 e7 MP e7 MP e7 MP




Figure 33. 6x6 grid results BEH Phenyl MeOH elution derivatized NH4F and ammonium 
bicarbonate. 
BEH Phenyl MeOH NH4F elution
19 20 21 22 23 24 25 26 27
Dopamine (ACN) e6 MP tailing e5 MP tailing e5 MP tailing
Dopamine (Ace) e6 MP tailing e5 MP tailing e5 MP tailing
Dopamine (EA) e6 MP tailing e5 MP tailing e5 MP tailing
Noradrenaline (ACN) e5 MP tailing e5 MP e5 MP e5 MP low sig
Noradrenaline (Ace) e5 MP tailing e5 MP e5 MP e5 MP low sig
Noradrenaline (EA) e5 MP tailing e5 MP e5 MP e5 MP low sig
Serotonin (ACN) e7 tailing e7 tailing e7 tailing
Serotonin (Ace) e6 MP tailing e6 tailing e6 MP tailing
Serotonin (EA) e6 MP tailing e6 tailing e6 MP tailing
Tyrosine (ACN) e7 MP tailing e7 MP tailing e6 MP tailing
Tyrosine (Ace) e7 MP tailing e7 MP tailing e7 MP tailing
Tyrosine (EA) e7 MP tailing e7 MP tailing e7 MP tailing
L-DOPA (ACN) e5 MP tailing e5 MP tailing e5 MP
L-DOPA (Ace) e5 MP tailing e5 MP tailing e5 MP
L-DOPA (EA) e5 MP tailing e5 MP tailing e5 MP
Tryptophan (ACN) e7 tailing e7 tailing e7 tailing
Tryptophan (Ace) e7 tailing e7 e7 tailing
Tryptophan (EA) e8 tailing e7 e7 tailing
5-hydroxytryptophan (ACN) e7 tailing e6 MP tailing e6 
5-hydroxytryptophan (Ace) e7 tailing e6 MP e6 MP
5-hydroxytryptophan(EA) e7 tailing e6 MP e6 MP
Tyramine (ACN) e7 MP tailing e7 tailing e7 MP tailing
Tyramine (Ace) e7 MP tailing e7 tailing e7 MP tailing
Tyramine (EA) e7 MP tailing e7 tailing e7 MP tailing
BEH Phenyl MeOH NH4Bicarbonate elution
28 29 30 31 32 33 34 35 36
Dopamine (ACN) e5 MP low sig low sig low sig broad
Dopamine (Ace) e5 MP low sig e5 MP e5 MP broad
Dopamine (EA) e5 MP e5 MP e5 MP e5 MP broad
Noradrenaline (ACN) e5 MP tailing fronting e5 MP
Noradrenaline (Ace) e5 MP tailing e5 MP tailing e5 MP
Noradrenaline (EA) e5 MP tailing e5 MP tailing e5 MP
Serotonin (ACN) e7 tailing e6 tailing tailing tailing
Serotonin (Ace) e6 tailing e6 tailing tailing tailing
Serotonin (EA) e6 tailing e6 tailing tailing tailing
Tyrosine (ACN) e7 MP tailing e7 MP tailing e7 MP tailing
Tyrosine (Ace) e7 MP tailing e7 MP tailing e7 MP tailing
Tyrosine (EA) e7 MP tailing e7 MP tailing e7 MP tailing
L-DOPA (ACN) e6 MP tailing e6 MP tailing e6 MP tailing
L-DOPA (Ace) e6 MP tailing e5 MP tailing e5 MP
L-DOPA (EA) e6 MP tailing tailing tailing e6 MP tailing
Tryptophan (ACN) e7 tailing e7 shoulder e7 tailing
Tryptophan (Ace) e8 tailing e7 shoulder e7 tailing
Tryptophan (EA) e8 tailing e7 shoulder e7 tailing
5-hydroxytryptophan (ACN) e7 tailing e7 shoulder e7 tailing
5-hydroxytryptophan (Ace) e7 tailing e7 shoulder e7 MP tailing
5-hydroxytryptophan(EA) e7 tailing e7 shoulder e7 tailing
Tyramine (ACN) e7 MP tailing e7 tailing e7 MP tailing
Tyramine (Ace) e8 MP tailing e7 tailing e7 MP tailing
Tyramine (EA) e8 MP tailing e7 MP tailing e7 MP tailing
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 The derivatized chromatography for each method showed significant improvement 
in intensity and the development of a gaussian peak shape.  Most of the methods resulted 
in a green indication including some that were green for every sample.  The HSS T3 column 
had all green boxes for method 7 and 19, both of which were under pH 3 elution (Figure 
28).  BEH C18 showed success for all under methods 4, 7, 10, 13, 22, 25, and 28 (Figure 
29 and 30). The most improved column was the BEH Phenyl under ACN pH 3 and 10 
which were completely successful with the exception of method 4 and 9 which had one 
yellow box and method 13 which had two (Figure 32).  MeOH methods for the BEH Phenyl 
column showed success in methods 19, 22, 25, and 28 (Figure 33). Results for the 
chromatography show that the derivatization process was an effective means of altering 
the structure of the neurotransmitters in order to achieve cleaner and more intense spectra. 
If used for extraction later, the ideal method would be method 10 using the BEH Phenyl 
column in conjunction with a C8 trap column under ACN elution at pH 10 and loading at 
pH 10 (Figure 32). Each resulting spectra had decent intensity and a desirable gaussian 
peak shape which is far improved from the pre-derivatization stage. 
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CONCLUSIONS 
The study examined neurotransmitters before and after derivatization to determine whether 
or not the derivatization process could provide an improvement in chromatography.  
Neurotransmitters are challenging compounds to analyze due to their sensitivity to pH and 
light as well as spontaneous oxidation, low availability, and multiple pKa values. Current 
methods of analysis are time consuming and require complex processes. With the use of 
derivatization and multidimensional liquid chromatography, the preparation takes only an 
hour to prepare and has a run time of ten minutes per injection.  The resulting 
chromatography gives intense gaussian-shaped peaks with clean separation.  The overall 
run time for each sample is significantly less that traditional HPLC setups and can use the 
same reagents at smaller quantities.  Sample lists can be automated for overnight and 
weekend runs which can save time on the part of the analyst and maximizes the instrument 
productivity. 
FUTURE DIRECTIONS 
Further study can be done by applying the derivatization process to different 
matrices such as plasma and urine to see how the sample preparation process affects the 
results as well as examine matrix recovery and interferences. The method developed was 
intended to be used in with SPE as sample preparation, and a comparison can be made as 
to when to apply the derivatization process: before or after sample preparation.  As 
mentioned above, more derivatization agents are available to be applied to amine 
functionality and future studies could examine their effectiveness for neurotransmitters. 
Additionally, the neurotransmitters included in the study only represent a small portion of 
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what is present in the body and further research could be done on other amines as well as 




LIST OF JOURNAL ABBREVIATIONS 
 
Anal Bioanal Chem   Analytical and Bioanalytical Chemistry 
 
Anal Chem     Analytical Chemistry 
 
Anal Chim Acta                     Analytica Chimica Acta 
 
Ann Clin Biochem  Analytical Investigation Standing Committee of the   
Association of Clinical Biochemistry 
 
Chem Neuro   ACS Chemical Neuroscience 
 
Int J Analytical Mass             International Journal of Analytical Mass Spectrometry and 
Chromatography 
 
J Chrom A    Journal of Chromatography A 
 
J Chrom B    Journal of Chromatography B 
 







1. Skov-Skov Bergh M, Bogen IL, Lundanes E, Øisetad AML. Validated methods for 
determination of neurotransmitters and metabolites and extracellular fluid by reversed 
phase UHPLC-MS/MS. J Chrom B 2016;1028:120-129. 
 
2. Kailasa SK, Wu H-F. Recent Advances in Mass Spectrometry for the Identification of 
Neurochemicals and their Metabolites in Biofluids. Current Neuropharmacology 
2013;11:436-464. 
 
3. Iversen L. Neurotransmitter transporters and their impact on the development of 
psychopharmacology.   British Journal of Pharmacology 2016;147:S82-S88.  
 
4. Kim M, Lee J, Yang CH, Lee S. Silica stationary phase-based on-line sample 
enrichment coupled with LC-MS/MS for the quantification of dopamine, serotonin, and 
their metabolites in rat brain microdialysates. Anal Chim Acta 2016;923:55-65. 
 
5. Zhang D, Wu L, C DSL, Tam VH, Rios DR. Quantitative determination of dopamine 
in human plasma by a highly sensitive LC-MS/MS assay: Application in preterm 
neonates. J Pharm Biomed Anal 2016;117:227-231. 
 
6. Han X-M, Qin Y-J, Zhu Y, Zhang X-L, Wang N-X, Rang Y, et al. Development of an 
underivatized LC-MS/MS method for quantitation of 14 neurotransmitters in rat 
hippocampus, plasma, and urine: Application to CUMS induced depression rats. J 
Pharm Biomed Anal 2019;174:683-695. 
 
7. Poh EZ, Hahne D, Moretti J, Harvey AR, Clarke MW, Rodger J. Simultaneous 
quantification of dopamine, serotonin, their metabolites and amino acids by LC/MS-
MS in mouse brain following repetitive transcranial magnetic stimulation. 
Neurochemistry International 2019;131:104546. 
 
8. Li W, Rossi DT, Fountain ST. Development and validation of a semi-automated 
method for L-dopa and dopamine in rat plasma using electrospray LC/MS/MS. J Pharm 
Biomed Anal 2000;24:325-333. 
 
9. Lakkappa N, Krishamurthy PT, Yamjala K, Hwang SH, Hammock BD, Babu B. 
Evaluation of antiparkinson activity of PTUPB by measuring dopamine and its 
metabolites in Drosophila melanogaster: LC-MS/MS method development. J Pharm 
Biomed Anal 2018;149:457-464. 
 
10. Taylor RL, Singh RJ. Validation of Liquid Chromatography-Tandem Mass 
Spectrometry Method for Analysis of Urinary Conjugated Metanephrine and 




11. Peaston RT, Weinkove C. Measurement of catecholamines and their metabolites. Ann 
Clin Biochem 2004;41:17-38. 
 
12. Lu J, Hu W, Cao W, Xie S, Li Z, Tao Y, et al. Rapid and Reproducible Dibutylation 
Derivatization Coupled with Ultra-High Performance Liquid Chromatography-
Tandem Mass Spectrometry for the Simultaneous Determination of Dopamine, 
Norepinephrine and 5-Hydroxytryptamine in Rat Brain Micrdialysates. Int J Analytical 
Mass 2018;6:21-36. 
 
13. De Jong WHA, Wilkens MHLI, de Vries EGE, Kema IP. Automated mass 
spectrometric analysis of urinary and plasma serotonin. Anal Bioanal Chem 
2010;396:2609-2616. 
 
14. Van der Gronde T, Kempes M, van El C, Rinne T, Pieters T. Neurobiological 
Correlates in a Forensic Assessment: A Systematic Review. PLOS One 2014;9(10):1-
15. 
 
15. Mallet C, Botch-Jones S. Illicit Drug Analysis Using 2D LC-MS/MS for Forensic 
Toxicology. Waters Corporation 2017. 720005533EN. 
 
16. Su Y, Xia S, Wang R, Xiao L. 13 – Phytohormonal quantification based on biological 
principles. In: Li J, Li C, Smith S, editors. Hormone Metabolism and Signaling in 
Plants. Changsha, China: Academic Press, 2017;431-470. 
 
17. Krull IS, Strong RS. CHROMATOGRAPHY: LIQUID |Derivatization. In: Cooke M, 
Poole CF, editors. Encyclopedia of Separation Science. Cheshire, UK: Academic Press, 
2000;583-591. 
 
18. Lkhagva A, Shen CC, Lueng YS, Tai HC. Comparative study of five different amine-
derivatization methods for metabolite analysis by liquid chromatography-tandem mass 
spectrometry. J Chrom A 2019;16:59. 
 
19. Uutela P, Ketola RA, Piepponen P, Kostiainen R. Comparison of different amino acid 
derivatives and analysis of rat brain microdialysates by liquid chromatography tandem 
mass spectrometry. Anal Chim Acta 2009;633:23-231. 
 
20. Anari MR, Bakhtiar R, Zhu B, Huskey S, Franklin RB, Evans DC. Derivatization of 
Ethinylestradiol with Dansyl Chloride To Enhance Electrospray Ionization: 
Application in Trace Analysis of Ethinylestradiol in Rhesus Monkey Plasma. Anal 
Chem 2002;74:4136-4144. 
 
21. Beaudry F, Guénette SA, Winterborn A, Marier JF, Vachon P. Development of a rapid 
and sensitive LC-ESI/MS/MS assay for the quantification of propofol using a simple 
52 
off-line dansyl chloride derivatization reaction to enhance signal intensity. J Pharm 
Biomed Anal 2005;39:411-417. 
 
 
22. Nirogi R, Komarneni P, Kandikere V, Boggavarapu R, Bhyrapuneni G, Benade V, et 
al. A sensitive and selective quantification of catecholamine neurotransmitters in rat 
microdialysates by pre-column dansyl chloride derivatization using liquid 
chromatography-tandem mass spectrometry. J Chrom B 2013;914:41-47. 
 
23. Rebane R, Oldekop ML, Herodes K. Comparison of amino acid derivatization reagents 
for LC-ESI-MS analysis. Introducing a novel phosphazene-based derivatization 
reagent. J Chrom B 2012;904:99-106. 
 
24. Mohammadi B, Tammari E, Fakhri S, Bahrami G. Applicability of LC-MS/MS to 
optimize derivatization of topiramate with FMOC-Cl using reacted/intact drug ratio. J 
Chrom B 2013;928:32-36. 
 
25. Reinhoud NJ, Brouwer HJ, van Heerwaarden LM, Korte-Bouws GAH. Analysis of 
Glutamate, GABA, Noradrenaline, Dopamine, Serotonin, and Metabolites Using 
Microbore UHPLC with Electrochemical Detection. Chem Neuro 2013;4:888-894. 
 
26. Lacroix C, Saussereau E. Fast liquid chromatography/tandem mass spectrometry 
determination of cannabinoids in micro volume blood samples after dabsyl 
derivatization. J Chrom B 2012;905:85-95. 
 
27. Luo YR, Han J, Yun C, Lynch KL. Azo coupling-based derivatization method for high-
sensitivity liquid chromatography-tandem mass spectrometry analysis of 
tetrahydrocannabinol and other aromatic compounds. J Chrom A 2019;1597:109-118. 
 
28. Zhang M, Fang C, Smagin G. Derivatization for the simultaneous LC/MS 
quantification of multiple neurotransmitters in extracellular fluid from rat brain 
microdialysis. J Pharm Biomed Anal 2014;100:357-364. 
 
29. Herráez-Hernández R, Campíns-Falco P. Derivatization of tertiary amphetamines with 
9-fluorenylmethyl chloroformate for liquid chromatography: determination of N-
methylephedrine. Analyst 2000;125:1071-1076. 
 
30. Bartram K, Federico M, Gardner J, George O, Hwang H, Shaine M, et al. Novel 
Extraction Techniques Using Acquity UPLC with 2D Technology: Part IV – First Time 





31. Mella M, Schweitzer B, Botch-Jones S, Moore T, Mallet CR.  Detection of Cocaine 
and its Major Metabolites in Rodent Bone Following Outdoor Decomposition after 
Cocaine Administration Using ACQUITY UPLC System with 2D Technology.  Waters 
Corporation 2016. 720005847EN. 
 
32. Botch-Jones S, Mallet CR. Novel Extraction Techniques ACQUITY UPLC with 2D 
Technology: Part II Ketamine and Xylazine in Bone Matrix. Waters Corporation 2019. 
720006587EN. 
 
33. Samuel J, Botch-Jones S, Mallet CR. Novel Extraction Techniques with ACQUITY 
UPLC with 2D Technology: Part I Pesticides Screening in Drinking Water. Waters 
Corporation 2019. 720006588EN. 
 
34. Mella M, Schweitzer B, Botch-Jones SR, Mallet CR, Kemp P, Cliburn K, et al. Rapid 
Analysis of Pharmaceuticals in Human Tissues Using the ACQUITY UPLC with 2D 
Technology. Waters Corporation 2017. 720005896EN 
 
35. Mella M, Schweitzer B, Botch-Jones SR, Mallet C. Analysis of Ketamine and Xylazine 
in Rat Tissues Using the ACQUITY UPLC with 2D Technology. Waters Corporation 
2016. 720005810EN. 
 
36. Benvenuto K, Botch-Jones SR, Mallet CR. Analysis of Synthetic Cannabinoids in 
Urine, Plasma, and Edibles Using Multidimensional UPLC Technology. Waters 
Corporation 2017. 720006015EN. 
 
37. Wikipedia. Norepinephrine.  https://en.wikipedia.org/wiki/Norepinephrine (accessed 
May 26, 2020). 
 
38. Wikipedia. Dopamine. https://en.wikipedia.org/wiki/Dopamine (accessed May 26, 
2020). 
 
39. Wikipedia. Tyramine. https://en.wikipedia.org/wiki/Tyramine (accessed May 26, 
2020). 
 
40. Wikipedia. Tyrosine. https://en.wikipedia.org/wiki/Tyrosine (accessed May 26, 
2020). 
 
41. Wikipedia. L-DOPA. https://en.wikipedia.org/wiki/L-DOPA (accessed May 26, 
2020). 
 








CURRICULUM VITAE  
                       
 
56 
